120 related articles for article (PubMed ID: 8163665)
1. Human small cell lung cancer cell lines expressing the proopiomelanocortin gene have aberrant glucocorticoid receptor function.
Ray DW; Littlewood AC; Clark AJ; Davis JR; White A
J Clin Invest; 1994 Apr; 93(4):1625-30. PubMed ID: 8163665
[TBL] [Abstract][Full Text] [Related]
2. Analysis of co-factor function in a glucocorticoid-resistant small cell carcinoma cell line.
Waters CE; Stevens A; White A; Ray DW
J Endocrinol; 2004 Nov; 183(2):375-83. PubMed ID: 15531725
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid receptor structure and function in glucocorticoid-resistant small cell lung carcinoma cells.
Ray DW; Davis JR; White A; Clark AJ
Cancer Res; 1996 Jul; 56(14):3276-80. PubMed ID: 8764121
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoid receptor overexpression exerts an antisurvival effect on human small cell lung cancer cells.
Sommer P; Le Rouzic P; Gillingham H; Berry A; Kayahara M; Huynh T; White A; Ray DW
Oncogene; 2007 Nov; 26(50):7111-21. PubMed ID: 17496926
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoid inhibition of ACTH peptides: small cell lung cancer cell lines are more resistant than pituitary corticotroph adenoma cells.
Farrell WE; Stewart MF; Clark AJ; Crosby SR; Davis JR; White A
J Mol Endocrinol; 1993 Feb; 10(1):25-32. PubMed ID: 8383976
[TBL] [Abstract][Full Text] [Related]
6. Bromocriptine inhibits pro-opiomelanocortin mRNA and ACTH precursor secretion in small cell lung cancer cell lines.
Farrell WE; Clark AJ; Stewart MF; Crosby SR; White A
J Clin Invest; 1992 Sep; 90(3):705-10. PubMed ID: 1325994
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the human proopiomelanocortin gene promoter in a small cell lung carcinoma cell line reveals an unusual role for E2F transcription factors.
Picon A; Bertagna X; de Keyzer Y
Oncogene; 1999 Apr; 18(16):2627-33. PubMed ID: 10353606
[TBL] [Abstract][Full Text] [Related]
8. Defective glucocorticoid regulation of proopiomelanocortin gene expression and peptide secretion in a small cell lung cancer cell line.
Clark AJ; Stewart MF; Lavender PM; Farrell W; Crosby SR; Rees LH; White A
J Clin Endocrinol Metab; 1990 Feb; 70(2):485-90. PubMed ID: 1967615
[TBL] [Abstract][Full Text] [Related]
9. Resistance to glucocorticoid-induced apoptosis in human T-cell acute lymphoblastic leukemia CEM-C1 cells is due to insufficient glucocorticoid receptor expression.
Geley S; Hartmann BL; Hala M; Strasser-Wozak EM; Kapelari K; Kofler R
Cancer Res; 1996 Nov; 56(21):5033-8. PubMed ID: 8895760
[TBL] [Abstract][Full Text] [Related]
10. c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions.
Ma PC; Kijima T; Maulik G; Fox EA; Sattler M; Griffin JD; Johnson BE; Salgia R
Cancer Res; 2003 Oct; 63(19):6272-81. PubMed ID: 14559814
[TBL] [Abstract][Full Text] [Related]
11. Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux.
Cohen AJ; Bunn PA; Franklin W; Magill-Solc C; Hartmann C; Helfrich B; Gilman L; Folkvord J; Helm K; Miller YE
Cancer Res; 1996 Feb; 56(4):831-9. PubMed ID: 8631021
[TBL] [Abstract][Full Text] [Related]
12. Association of the decreased expression of alpha3beta1 integrin with the altered cell: environmental interactions and enhanced soft agar cloning ability of c-myc-overexpressing small cell lung cancer cells.
Barr LF; Campbell SE; Bochner BS; Dang CV
Cancer Res; 1998 Dec; 58(23):5537-45. PubMed ID: 9850091
[TBL] [Abstract][Full Text] [Related]
13. Resistance of transformed mouse keratinocytes to growth inhibition by glucocorticoids.
Spiegelman VS; Budunova IV; Carbajal S; Slaga TJ
Mol Carcinog; 1997 Sep; 20(1):99-107. PubMed ID: 9328440
[TBL] [Abstract][Full Text] [Related]
14. Expression of nerve growth factor-induced clone B subfamily and pro-opiomelanocortin gene in lung cancer cell lines.
Ueda Y; Bandoh S; Fujita J; Sato M; Yamaji Y; Takahara J
Am J Respir Cell Mol Biol; 1999 Jun; 20(6):1319-25. PubMed ID: 10340952
[TBL] [Abstract][Full Text] [Related]
15. Loss of glucocorticoid-dependent growth inhibition in transformed mouse lung cells.
Li J; Johnson TA; Hanson LA; Beer DG
Mol Carcinog; 1996 Aug; 16(4):213-20. PubMed ID: 8784464
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid receptor expression in advanced non-small cell lung cancer: clinicopathological correlation and in vitro effect of glucocorticoid on cell growth and chemosensitivity.
Lu YS; Lien HC; Yeh PY; Kuo SH; Chang WC; Kuo ML; Cheng AL
Lung Cancer; 2006 Sep; 53(3):303-10. PubMed ID: 16806572
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid-induced cell death requires autoinduction of glucocorticoid receptor expression in human leukemic T cells.
Ramdas J; Liu W; Harmon JM
Cancer Res; 1999 Mar; 59(6):1378-85. PubMed ID: 10096574
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of the human delta opioid receptor in lung cancer.
Schreiber G; Campa MJ; Prabhakar S; O'Briant K; Bepler G; Patz EF
Anticancer Res; 1998; 18(3A):1787-92. PubMed ID: 9673405
[TBL] [Abstract][Full Text] [Related]
19. CCKA and CCKB receptors are expressed in small cell lung cancer lines and mediate Ca2+ mobilization and clonal growth.
Sethi T; Herget T; Wu SV; Walsh JH; Rozengurt E
Cancer Res; 1993 Nov; 53(21):5208-13. PubMed ID: 8221657
[TBL] [Abstract][Full Text] [Related]
20. Autocrine growth of small cell lung cancer mediated by coexpression of c-kit and stem cell factor.
Krystal GW; Hines SJ; Organ CP
Cancer Res; 1996 Jan; 56(2):370-6. PubMed ID: 8542594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
